nodes	percent_of_prediction	percent_of_DWPC	metapath
Docetaxel—lung cancer—thymus cancer	0.792	1	CtDrD
Docetaxel—Pain localised—Octreotide—thymus cancer	0.0136	0.119	CcSEcCtD
Docetaxel—GHRHR—pituitary gland—thymus cancer	0.00307	0.0381	CbGeAlD
Docetaxel—Haemorrhoids—Octreotide—thymus cancer	0.00266	0.0233	CcSEcCtD
Docetaxel—Nail disorder—Octreotide—thymus cancer	0.00241	0.0211	CcSEcCtD
Docetaxel—Redness—Octreotide—thymus cancer	0.00232	0.0203	CcSEcCtD
Docetaxel—Intestinal obstruction—Octreotide—thymus cancer	0.0023	0.0201	CcSEcCtD
Docetaxel—KIF11—bone marrow—thymus cancer	0.00226	0.028	CbGeAlD
Docetaxel—Neuralgia—Octreotide—thymus cancer	0.00225	0.0197	CcSEcCtD
Docetaxel—Burning sensation—Octreotide—thymus cancer	0.00225	0.0197	CcSEcCtD
Docetaxel—Throat sore—Octreotide—thymus cancer	0.00217	0.019	CcSEcCtD
Docetaxel—Oropharyngeal discomfort—Octreotide—thymus cancer	0.00215	0.0189	CcSEcCtD
Docetaxel—Neuritis—Octreotide—thymus cancer	0.0021	0.0184	CcSEcCtD
Docetaxel—KIF11—lung—thymus cancer	0.00205	0.0254	CbGeAlD
Docetaxel—Otitis media—Octreotide—thymus cancer	0.00201	0.0176	CcSEcCtD
Docetaxel—BCL2—neck—thymus cancer	0.00198	0.0246	CbGeAlD
Docetaxel—Extravasation—Octreotide—thymus cancer	0.00179	0.0157	CcSEcCtD
Docetaxel—Amenorrhoea—Octreotide—thymus cancer	0.00178	0.0156	CcSEcCtD
Docetaxel—Oropharyngeal pain—Octreotide—thymus cancer	0.00172	0.0151	CcSEcCtD
Docetaxel—Hyperbilirubinaemia—Octreotide—thymus cancer	0.00172	0.0151	CcSEcCtD
Docetaxel—MAP2—neck—thymus cancer	0.00172	0.0213	CbGeAlD
Docetaxel—Drug interaction—Octreotide—thymus cancer	0.00169	0.0148	CcSEcCtD
Docetaxel—Hearing impaired—Octreotide—thymus cancer	0.00164	0.0144	CcSEcCtD
Docetaxel—TUBB3—hematopoietic system—thymus cancer	0.00162	0.0201	CbGeAlD
Docetaxel—MAP4—hematopoietic system—thymus cancer	0.00162	0.0201	CbGeAlD
Docetaxel—TUBB1—hematopoietic system—thymus cancer	0.00159	0.0197	CbGeAlD
Docetaxel—Phosphatase alkaline increased—Octreotide—thymus cancer	0.00157	0.0137	CcSEcCtD
Docetaxel—Injection site reaction—Octreotide—thymus cancer	0.00156	0.0136	CcSEcCtD
Docetaxel—MAPT—pituitary gland—thymus cancer	0.00153	0.019	CbGeAlD
Docetaxel—Influenza like illness—Octreotide—thymus cancer	0.00152	0.0133	CcSEcCtD
Docetaxel—Candida infection—Octreotide—thymus cancer	0.00149	0.0131	CcSEcCtD
Docetaxel—BCL2—hematopoietic system—thymus cancer	0.00148	0.0183	CbGeAlD
Docetaxel—Neuropathy—Octreotide—thymus cancer	0.00147	0.0129	CcSEcCtD
Docetaxel—KIF11—lymph node—thymus cancer	0.0014	0.0173	CbGeAlD
Docetaxel—BCL2—epithelium—thymus cancer	0.00135	0.0167	CbGeAlD
Docetaxel—MAPT—thyroid gland—thymus cancer	0.00132	0.0164	CbGeAlD
Docetaxel—Phlebitis—Octreotide—thymus cancer	0.00132	0.0116	CcSEcCtD
Docetaxel—Thrombophlebitis—Octreotide—thymus cancer	0.00131	0.0115	CcSEcCtD
Docetaxel—Blood alkaline phosphatase increased—Octreotide—thymus cancer	0.00131	0.0114	CcSEcCtD
Docetaxel—MAP2—hematopoietic system—thymus cancer	0.00128	0.0159	CbGeAlD
Docetaxel—Deafness—Octreotide—thymus cancer	0.00127	0.0111	CcSEcCtD
Docetaxel—Cardiac failure congestive—Octreotide—thymus cancer	0.00125	0.011	CcSEcCtD
Docetaxel—Hot flush—Octreotide—thymus cancer	0.00121	0.0106	CcSEcCtD
Docetaxel—Menopausal symptoms—Octreotide—thymus cancer	0.0012	0.0105	CcSEcCtD
Docetaxel—Visual disturbance—Octreotide—thymus cancer	0.0012	0.0105	CcSEcCtD
Docetaxel—TUBB3—lymphoid tissue—thymus cancer	0.00114	0.0142	CbGeAlD
Docetaxel—MAP4—lymphoid tissue—thymus cancer	0.00114	0.0142	CbGeAlD
Docetaxel—Pain in extremity—Octreotide—thymus cancer	0.00114	0.00995	CcSEcCtD
Docetaxel—Gastrointestinal haemorrhage—Octreotide—thymus cancer	0.00114	0.00995	CcSEcCtD
Docetaxel—Dehydration—Octreotide—thymus cancer	0.00106	0.00926	CcSEcCtD
Docetaxel—SLCO1B3—pituitary gland—thymus cancer	0.00105	0.0131	CbGeAlD
Docetaxel—Dry skin—Octreotide—thymus cancer	0.00104	0.00912	CcSEcCtD
Docetaxel—BCL2—lymphoid tissue—thymus cancer	0.00104	0.0129	CbGeAlD
Docetaxel—MAP4—thyroid gland—thymus cancer	0.00104	0.0129	CbGeAlD
Docetaxel—Abdominal pain upper—Octreotide—thymus cancer	0.00104	0.00909	CcSEcCtD
Docetaxel—Cramp muscle—Octreotide—thymus cancer	0.00102	0.00896	CcSEcCtD
Docetaxel—TUBB1—bone marrow—thymus cancer	0.00102	0.0126	CbGeAlD
Docetaxel—Nasopharyngitis—Octreotide—thymus cancer	0.00102	0.0089	CcSEcCtD
Docetaxel—TUBB4A—hematopoietic system—thymus cancer	0.000988	0.0123	CbGeAlD
Docetaxel—MAP2—cardiac atrium—thymus cancer	0.000971	0.012	CbGeAlD
Docetaxel—Bronchospasm—Octreotide—thymus cancer	0.000966	0.00846	CcSEcCtD
Docetaxel—MAP2—pituitary gland—thymus cancer	0.000949	0.0118	CbGeAlD
Docetaxel—BCL2—bone marrow—thymus cancer	0.000946	0.0117	CbGeAlD
Docetaxel—BCL2—thyroid gland—thymus cancer	0.000944	0.0117	CbGeAlD
Docetaxel—TUBB3—lung—thymus cancer	0.000943	0.0117	CbGeAlD
Docetaxel—MAP4—lung—thymus cancer	0.000943	0.0117	CbGeAlD
Docetaxel—EGFR—thyroid gland—thymus cancer	0.000933	0.0116	CbGeAlD
Docetaxel—TUBB2A—hematopoietic system—thymus cancer	0.000899	0.0111	CbGeAlD
Docetaxel—Weight increased—Octreotide—thymus cancer	0.000894	0.00783	CcSEcCtD
Docetaxel—Weight decreased—Octreotide—thymus cancer	0.000889	0.00778	CcSEcCtD
Docetaxel—TUBB6—hematopoietic system—thymus cancer	0.000887	0.011	CbGeAlD
Docetaxel—Pneumonia—Octreotide—thymus cancer	0.000881	0.00772	CcSEcCtD
Docetaxel—Neuropathy peripheral—Octreotide—thymus cancer	0.000858	0.00752	CcSEcCtD
Docetaxel—BCL2—lung—thymus cancer	0.000857	0.0106	CbGeAlD
Docetaxel—Jaundice—Octreotide—thymus cancer	0.000854	0.00748	CcSEcCtD
Docetaxel—Conjunctivitis—Octreotide—thymus cancer	0.000851	0.00746	CcSEcCtD
Docetaxel—EGFR—lung—thymus cancer	0.000847	0.0105	CbGeAlD
Docetaxel—Hepatobiliary disease—Octreotide—thymus cancer	0.000828	0.00726	CcSEcCtD
Docetaxel—Epistaxis—Octreotide—thymus cancer	0.000826	0.00724	CcSEcCtD
Docetaxel—SLCO1B3—lung—thymus cancer	0.000826	0.0102	CbGeAlD
Docetaxel—MAPT—lymph node—thymus cancer	0.000821	0.0102	CbGeAlD
Docetaxel—MAP2—thyroid gland—thymus cancer	0.000818	0.0101	CbGeAlD
Docetaxel—TUBB6—epithelium—thymus cancer	0.000811	0.01	CbGeAlD
Docetaxel—Rhinitis—Octreotide—thymus cancer	0.000788	0.0069	CcSEcCtD
Docetaxel—Hepatitis—Octreotide—thymus cancer	0.000786	0.00689	CcSEcCtD
Docetaxel—Hypoaesthesia—Octreotide—thymus cancer	0.000782	0.00685	CcSEcCtD
Docetaxel—Pharyngitis—Octreotide—thymus cancer	0.00078	0.00683	CcSEcCtD
Docetaxel—ABCC10—hematopoietic system—thymus cancer	0.000776	0.00962	CbGeAlD
Docetaxel—Oedema peripheral—Octreotide—thymus cancer	0.000775	0.00678	CcSEcCtD
Docetaxel—TUBB4B—hematopoietic system—thymus cancer	0.000771	0.00956	CbGeAlD
Docetaxel—Visual impairment—Octreotide—thymus cancer	0.000758	0.00664	CcSEcCtD
Docetaxel—MAP2—lung—thymus cancer	0.000743	0.00921	CbGeAlD
Docetaxel—Flushing—Octreotide—thymus cancer	0.00073	0.00639	CcSEcCtD
Docetaxel—Cardiac disorder—Octreotide—thymus cancer	0.00073	0.00639	CcSEcCtD
Docetaxel—TUBB2B—cardiac atrium—thymus cancer	0.000725	0.00899	CbGeAlD
Docetaxel—Immune system disorder—Octreotide—thymus cancer	0.00071	0.00622	CcSEcCtD
Docetaxel—TUBB2B—pituitary gland—thymus cancer	0.000709	0.00878	CbGeAlD
Docetaxel—Arrhythmia—Octreotide—thymus cancer	0.000702	0.00615	CcSEcCtD
Docetaxel—TUBB4A—lymphoid tissue—thymus cancer	0.000696	0.00862	CbGeAlD
Docetaxel—Alopecia—Octreotide—thymus cancer	0.000695	0.00609	CcSEcCtD
Docetaxel—Mental disorder—Octreotide—thymus cancer	0.000689	0.00603	CcSEcCtD
Docetaxel—TUBB—cardiac atrium—thymus cancer	0.000686	0.00851	CbGeAlD
Docetaxel—Malnutrition—Octreotide—thymus cancer	0.000684	0.00599	CcSEcCtD
Docetaxel—Erythema—Octreotide—thymus cancer	0.000684	0.00599	CcSEcCtD
Docetaxel—TUBB2A—cardiac atrium—thymus cancer	0.000683	0.00846	CbGeAlD
Docetaxel—TUBB6—cardiac atrium—thymus cancer	0.000673	0.00835	CbGeAlD
Docetaxel—TUBB—pituitary gland—thymus cancer	0.00067	0.00831	CbGeAlD
Docetaxel—TUBB2A—pituitary gland—thymus cancer	0.000667	0.00827	CbGeAlD
Docetaxel—Back pain—Octreotide—thymus cancer	0.000662	0.0058	CcSEcCtD
Docetaxel—Muscle spasms—Octreotide—thymus cancer	0.000658	0.00576	CcSEcCtD
Docetaxel—TUBB6—pituitary gland—thymus cancer	0.000658	0.00815	CbGeAlD
Docetaxel—MAP4—lymph node—thymus cancer	0.000645	0.008	CbGeAlD
Docetaxel—Anaemia—Octreotide—thymus cancer	0.000633	0.00554	CcSEcCtD
Docetaxel—TUBB4A—thyroid gland—thymus cancer	0.000632	0.00783	CbGeAlD
Docetaxel—TUBB6—lymphoid tissue—thymus cancer	0.000624	0.00774	CbGeAlD
Docetaxel—Syncope—Octreotide—thymus cancer	0.000614	0.00538	CcSEcCtD
Docetaxel—TUBB2B—thyroid gland—thymus cancer	0.000611	0.00757	CbGeAlD
Docetaxel—CYP1B1—hematopoietic system—thymus cancer	0.000611	0.00757	CbGeAlD
Docetaxel—Palpitations—Octreotide—thymus cancer	0.000605	0.0053	CcSEcCtD
Docetaxel—Loss of consciousness—Octreotide—thymus cancer	0.000602	0.00527	CcSEcCtD
Docetaxel—Cough—Octreotide—thymus cancer	0.000597	0.00523	CcSEcCtD
Docetaxel—Convulsion—Octreotide—thymus cancer	0.000593	0.00519	CcSEcCtD
Docetaxel—Hypertension—Octreotide—thymus cancer	0.000591	0.00518	CcSEcCtD
Docetaxel—ABCC10—cardiac atrium—thymus cancer	0.00059	0.00731	CbGeAlD
Docetaxel—BCL2—lymph node—thymus cancer	0.000586	0.00727	CbGeAlD
Docetaxel—TUBB4B—cardiac atrium—thymus cancer	0.000585	0.00726	CbGeAlD
Docetaxel—Arthralgia—Octreotide—thymus cancer	0.000583	0.0051	CcSEcCtD
Docetaxel—Chest pain—Octreotide—thymus cancer	0.000583	0.0051	CcSEcCtD
Docetaxel—Myalgia—Octreotide—thymus cancer	0.000583	0.0051	CcSEcCtD
Docetaxel—EGFR—lymph node—thymus cancer	0.000579	0.00718	CbGeAlD
Docetaxel—TUBB—bone marrow—thymus cancer	0.000579	0.00718	CbGeAlD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.000579	0.00507	CcSEcCtD
Docetaxel—TUBB—thyroid gland—thymus cancer	0.000578	0.00716	CbGeAlD
Docetaxel—TUBB2A—bone marrow—thymus cancer	0.000576	0.00715	CbGeAlD
Docetaxel—ABCC10—pituitary gland—thymus cancer	0.000576	0.00714	CbGeAlD
Docetaxel—TUBB2A—thyroid gland—thymus cancer	0.000575	0.00713	CbGeAlD
Docetaxel—TUBB4A—lung—thymus cancer	0.000574	0.00712	CbGeAlD
Docetaxel—TUBB4B—pituitary gland—thymus cancer	0.000572	0.00709	CbGeAlD
Docetaxel—Dry mouth—Octreotide—thymus cancer	0.00057	0.00499	CcSEcCtD
Docetaxel—TUBB6—bone marrow—thymus cancer	0.000568	0.00705	CbGeAlD
Docetaxel—TUBB6—thyroid gland—thymus cancer	0.000567	0.00703	CbGeAlD
Docetaxel—Anaphylactic shock—Octreotide—thymus cancer	0.000559	0.00489	CcSEcCtD
Docetaxel—Oedema—Octreotide—thymus cancer	0.000559	0.00489	CcSEcCtD
Docetaxel—Infection—Octreotide—thymus cancer	0.000555	0.00486	CcSEcCtD
Docetaxel—TUBB2B—lung—thymus cancer	0.000555	0.00688	CbGeAlD
Docetaxel—Shock—Octreotide—thymus cancer	0.00055	0.00481	CcSEcCtD
Docetaxel—Nervous system disorder—Octreotide—thymus cancer	0.000548	0.0048	CcSEcCtD
Docetaxel—Thrombocytopenia—Octreotide—thymus cancer	0.000547	0.00479	CcSEcCtD
Docetaxel—ABCC10—lymphoid tissue—thymus cancer	0.000547	0.00678	CbGeAlD
Docetaxel—Tachycardia—Octreotide—thymus cancer	0.000545	0.00478	CcSEcCtD
Docetaxel—TUBB4B—lymphoid tissue—thymus cancer	0.000543	0.00673	CbGeAlD
Docetaxel—Skin disorder—Octreotide—thymus cancer	0.000543	0.00475	CcSEcCtD
Docetaxel—Anorexia—Octreotide—thymus cancer	0.000532	0.00466	CcSEcCtD
Docetaxel—TUBB—lung—thymus cancer	0.000525	0.00651	CbGeAlD
Docetaxel—TUBB2A—lung—thymus cancer	0.000522	0.00647	CbGeAlD
Docetaxel—TUBB6—lung—thymus cancer	0.000515	0.00638	CbGeAlD
Docetaxel—Musculoskeletal discomfort—Octreotide—thymus cancer	0.000509	0.00446	CcSEcCtD
Docetaxel—MAP2—lymph node—thymus cancer	0.000508	0.0063	CbGeAlD
Docetaxel—MAPT—Notch Signaling Pathway—MAML2—thymus cancer	0.000508	0.039	CbGpPWpGaD
Docetaxel—Insomnia—Octreotide—thymus cancer	0.000505	0.00443	CcSEcCtD
Docetaxel—Paraesthesia—Octreotide—thymus cancer	0.000502	0.00439	CcSEcCtD
Docetaxel—Dyspnoea—Octreotide—thymus cancer	0.000498	0.00436	CcSEcCtD
Docetaxel—ABCC10—bone marrow—thymus cancer	0.000498	0.00617	CbGeAlD
Docetaxel—Somnolence—Octreotide—thymus cancer	0.000497	0.00435	CcSEcCtD
Docetaxel—ABCC10—thyroid gland—thymus cancer	0.000496	0.00615	CbGeAlD
Docetaxel—TUBB4B—bone marrow—thymus cancer	0.000494	0.00613	CbGeAlD
Docetaxel—TUBB4B—thyroid gland—thymus cancer	0.000493	0.00611	CbGeAlD
Docetaxel—Dyspepsia—Octreotide—thymus cancer	0.000492	0.00431	CcSEcCtD
Docetaxel—Decreased appetite—Octreotide—thymus cancer	0.000486	0.00425	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Octreotide—thymus cancer	0.000482	0.00422	CcSEcCtD
Docetaxel—Fatigue—Octreotide—thymus cancer	0.000482	0.00422	CcSEcCtD
Docetaxel—Pain—Octreotide—thymus cancer	0.000478	0.00418	CcSEcCtD
Docetaxel—Constipation—Octreotide—thymus cancer	0.000478	0.00418	CcSEcCtD
Docetaxel—BCL2—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—CYLD—thymus cancer	0.000461	0.0354	CbGpPWpGaD
Docetaxel—Feeling abnormal—Octreotide—thymus cancer	0.00046	0.00403	CcSEcCtD
Docetaxel—Gastrointestinal pain—Octreotide—thymus cancer	0.000457	0.004	CcSEcCtD
Docetaxel—CYP1B1—pituitary gland—thymus cancer	0.000453	0.00561	CbGeAlD
Docetaxel—ABCC10—lung—thymus cancer	0.000451	0.00559	CbGeAlD
Docetaxel—TUBB4B—lung—thymus cancer	0.000448	0.00555	CbGeAlD
Docetaxel—Body temperature increased—Octreotide—thymus cancer	0.000442	0.00387	CcSEcCtD
Docetaxel—Abdominal pain—Octreotide—thymus cancer	0.000442	0.00387	CcSEcCtD
Docetaxel—CYP1B1—lymphoid tissue—thymus cancer	0.00043	0.00533	CbGeAlD
Docetaxel—CYP3A5—hematopoietic system—thymus cancer	0.000422	0.00523	CbGeAlD
Docetaxel—ABCC1—cardiac atrium—thymus cancer	0.000417	0.00517	CbGeAlD
Docetaxel—Hypersensitivity—Octreotide—thymus cancer	0.000412	0.0036	CcSEcCtD
Docetaxel—ABCC1—pituitary gland—thymus cancer	0.000407	0.00505	CbGeAlD
Docetaxel—Asthenia—Octreotide—thymus cancer	0.000401	0.00351	CcSEcCtD
Docetaxel—Pruritus—Octreotide—thymus cancer	0.000395	0.00346	CcSEcCtD
Docetaxel—TUBB4A—lymph node—thymus cancer	0.000393	0.00487	CbGeAlD
Docetaxel—CYP1B1—thyroid gland—thymus cancer	0.00039	0.00484	CbGeAlD
Docetaxel—Diarrhoea—Octreotide—thymus cancer	0.000382	0.00335	CcSEcCtD
Docetaxel—TUBB2B—lymph node—thymus cancer	0.000379	0.0047	CbGeAlD
Docetaxel—Dizziness—Octreotide—thymus cancer	0.000369	0.00324	CcSEcCtD
Docetaxel—TUBB—lymph node—thymus cancer	0.000359	0.00445	CbGeAlD
Docetaxel—TUBB2A—lymph node—thymus cancer	0.000357	0.00443	CbGeAlD
Docetaxel—Vomiting—Octreotide—thymus cancer	0.000355	0.00311	CcSEcCtD
Docetaxel—CYP1B1—lung—thymus cancer	0.000355	0.0044	CbGeAlD
Docetaxel—TUBB6—lymph node—thymus cancer	0.000352	0.00437	CbGeAlD
Docetaxel—Rash—Octreotide—thymus cancer	0.000352	0.00308	CcSEcCtD
Docetaxel—Dermatitis—Octreotide—thymus cancer	0.000352	0.00308	CcSEcCtD
Docetaxel—ABCC1—thyroid gland—thymus cancer	0.000351	0.00435	CbGeAlD
Docetaxel—Headache—Octreotide—thymus cancer	0.00035	0.00307	CcSEcCtD
Docetaxel—ABCG2—pituitary gland—thymus cancer	0.000337	0.00418	CbGeAlD
Docetaxel—Nausea—Octreotide—thymus cancer	0.000332	0.00291	CcSEcCtD
Docetaxel—ABCC1—lung—thymus cancer	0.000319	0.00395	CbGeAlD
Docetaxel—CYP3A4—hematopoietic system—thymus cancer	0.000317	0.00393	CbGeAlD
Docetaxel—ABCC10—lymph node—thymus cancer	0.000308	0.00382	CbGeAlD
Docetaxel—TUBB4B—lymph node—thymus cancer	0.000306	0.0038	CbGeAlD
Docetaxel—BCL2—TP53 Network—CDKN2A—thymus cancer	0.000298	0.0228	CbGpPWpGaD
Docetaxel—ABCG2—bone marrow—thymus cancer	0.000291	0.00361	CbGeAlD
Docetaxel—ABCG2—thyroid gland—thymus cancer	0.000291	0.0036	CbGeAlD
Docetaxel—ABCG2—lung—thymus cancer	0.000264	0.00327	CbGeAlD
Docetaxel—MAP2—LKB1 signaling events—TP53—thymus cancer	0.00025	0.0192	CbGpPWpGaD
Docetaxel—ABCC2—lymph node—thymus cancer	0.000248	0.00307	CbGeAlD
Docetaxel—CYP3A5—lung—thymus cancer	0.000245	0.00304	CbGeAlD
Docetaxel—CYP1B1—lymph node—thymus cancer	0.000243	0.00301	CbGeAlD
Docetaxel—MAPT—Kit receptor signaling pathway—KIT—thymus cancer	0.000241	0.0185	CbGpPWpGaD
Docetaxel—MAPT—IL-5 Signaling Pathway—IL2—thymus cancer	0.000231	0.0178	CbGpPWpGaD
Docetaxel—ABCB1—hematopoietic system—thymus cancer	0.000224	0.00278	CbGeAlD
Docetaxel—MAPT—IL-2 Signaling Pathway—IL2—thymus cancer	0.000222	0.0171	CbGpPWpGaD
Docetaxel—ABCC1—lymph node—thymus cancer	0.000218	0.0027	CbGeAlD
Docetaxel—ABCB1—epithelium—thymus cancer	0.000205	0.00254	CbGeAlD
Docetaxel—ABCG2—lymph node—thymus cancer	0.000181	0.00224	CbGeAlD
Docetaxel—BCL2—IL2 signaling events mediated by STAT5—IL2—thymus cancer	0.000179	0.0137	CbGpPWpGaD
Docetaxel—BCL2—Activation of BAD and translocation to mitochondria—AKT1—thymus cancer	0.000169	0.013	CbGpPWpGaD
Docetaxel—MAPT—Reelin signaling pathway—AKT1—thymus cancer	0.000167	0.0128	CbGpPWpGaD
Docetaxel—BCL2—Signaling events mediated by Stem cell factor receptor (c-Kit)—KIT—thymus cancer	0.000166	0.0128	CbGpPWpGaD
Docetaxel—ABCB1—pituitary gland—thymus cancer	0.000166	0.00206	CbGeAlD
Docetaxel—BCL2—TP53 Network—TP53—thymus cancer	0.000166	0.0127	CbGpPWpGaD
Docetaxel—ABCB1—lymphoid tissue—thymus cancer	0.000158	0.00196	CbGeAlD
Docetaxel—BCL2—IL2 signaling events mediated by PI3K—IL2—thymus cancer	0.000151	0.0116	CbGpPWpGaD
Docetaxel—BCL2—Kit receptor signaling pathway—KIT—thymus cancer	0.000148	0.0114	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—DPYSL5—thymus cancer	0.000147	0.0113	CbGpPWpGaD
Docetaxel—KIF11—Immune System—CYLD—thymus cancer	0.000145	0.0111	CbGpPWpGaD
Docetaxel—ABCB1—bone marrow—thymus cancer	0.000144	0.00178	CbGeAlD
Docetaxel—ABCB1—thyroid gland—thymus cancer	0.000143	0.00178	CbGeAlD
Docetaxel—BCL2—IL-5 Signaling Pathway—IL2—thymus cancer	0.000142	0.0109	CbGpPWpGaD
Docetaxel—MAPT—LKB1 signaling events—TP53—thymus cancer	0.00014	0.0108	CbGpPWpGaD
Docetaxel—BCL2—IL-2 Signaling Pathway—IL2—thymus cancer	0.000137	0.0105	CbGpPWpGaD
Docetaxel—BCL2—Activation of BH3-only proteins—TP53—thymus cancer	0.000133	0.0102	CbGpPWpGaD
Docetaxel—KIF11—Factors involved in megakaryocyte development and platelet production—TP53—thymus cancer	0.000131	0.0101	CbGpPWpGaD
Docetaxel—ABCB1—lung—thymus cancer	0.00013	0.00161	CbGeAlD
Docetaxel—MAPT—IL-5 Signaling Pathway—AKT1—thymus cancer	0.000125	0.00963	CbGpPWpGaD
Docetaxel—MAPT—IL-2 Signaling Pathway—AKT1—thymus cancer	0.000121	0.00926	CbGpPWpGaD
Docetaxel—MAPT—Copper homeostasis—TP53—thymus cancer	0.00012	0.00924	CbGpPWpGaD
Docetaxel—BCL2—Estrogen signaling pathway—AKT1—thymus cancer	0.00012	0.00922	CbGpPWpGaD
Docetaxel—EGFR—Bladder Cancer—CDKN2A—thymus cancer	0.000119	0.00913	CbGpPWpGaD
Docetaxel—KIF11—Adaptive Immune System—CD8A—thymus cancer	0.000117	0.00898	CbGpPWpGaD
Docetaxel—TUBB2A—Signaling events mediated by HDAC Class III—TP53—thymus cancer	0.000114	0.00875	CbGpPWpGaD
Docetaxel—BCL2—Activation of BH3-only proteins—AKT1—thymus cancer	0.000112	0.00862	CbGpPWpGaD
Docetaxel—BCL2—IL2-mediated signaling events—IL2—thymus cancer	0.000112	0.00859	CbGpPWpGaD
Docetaxel—BCL2—C-MYB transcription factor network—KIT—thymus cancer	0.000112	0.00857	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—DPYSL5—thymus cancer	0.000105	0.00806	CbGpPWpGaD
Docetaxel—MAPT—Copper homeostasis—AKT1—thymus cancer	0.000102	0.0078	CbGpPWpGaD
Docetaxel—SLC22A7—Fluoropyrimidine Activity—TP53—thymus cancer	9.95e-05	0.00764	CbGpPWpGaD
Docetaxel—NR1I2—Generic Transcription Pathway—MAML2—thymus cancer	9.89e-05	0.0076	CbGpPWpGaD
Docetaxel—BCL2—Intrinsic Pathway for Apoptosis—TP53—thymus cancer	9.51e-05	0.0073	CbGpPWpGaD
Docetaxel—BCL2—Amyotrophic lateral sclerosis (ALS)—TP53—thymus cancer	9.51e-05	0.0073	CbGpPWpGaD
Docetaxel—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—thymus cancer	9.48e-05	0.00728	CbGpPWpGaD
Docetaxel—MAPT—Kit receptor signaling pathway—AKT1—thymus cancer	9.19e-05	0.00705	CbGpPWpGaD
Docetaxel—BCL2—C-MYB transcription factor network—CDKN2A—thymus cancer	9.06e-05	0.00696	CbGpPWpGaD
Docetaxel—BCL2—Apoptosis—CDKN2A—thymus cancer	9.06e-05	0.00696	CbGpPWpGaD
Docetaxel—MAPT—Notch Signaling Pathway—AKT1—thymus cancer	8.95e-05	0.00687	CbGpPWpGaD
Docetaxel—ABCB1—lymph node—thymus cancer	8.91e-05	0.0011	CbGeAlD
Docetaxel—KIF11—Adaptive Immune System—KIT—thymus cancer	8.78e-05	0.00674	CbGpPWpGaD
Docetaxel—MAPT—Alzheimers Disease—TP53—thymus cancer	8.61e-05	0.00661	CbGpPWpGaD
Docetaxel—MAPT—LPA receptor mediated events—AKT1—thymus cancer	8.61e-05	0.00661	CbGpPWpGaD
Docetaxel—BCL2—C-MYB transcription factor network—CD4—thymus cancer	8.54e-05	0.00655	CbGpPWpGaD
Docetaxel—BCL2—Apoptosis Modulation and Signaling—CDKN2A—thymus cancer	8.5e-05	0.00653	CbGpPWpGaD
Docetaxel—BCL2—Integrated Cancer Pathway—TP53—thymus cancer	8.46e-05	0.00649	CbGpPWpGaD
Docetaxel—BCL2—IL2 signaling events mediated by PI3K—AKT1—thymus cancer	8.21e-05	0.0063	CbGpPWpGaD
Docetaxel—BCL2—Intrinsic Pathway for Apoptosis—AKT1—thymus cancer	8.03e-05	0.00617	CbGpPWpGaD
Docetaxel—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL2—thymus cancer	7.71e-05	0.00592	CbGpPWpGaD
Docetaxel—BCL2—IL-5 Signaling Pathway—AKT1—thymus cancer	7.71e-05	0.00592	CbGpPWpGaD
Docetaxel—EGFR—E-cadherin signaling in keratinocytes—AKT1—thymus cancer	7.63e-05	0.00586	CbGpPWpGaD
Docetaxel—BCL2—Senescence and Autophagy in Cancer—CDKN2A—thymus cancer	7.58e-05	0.00582	CbGpPWpGaD
Docetaxel—EGFR—Aryl Hydrocarbon Receptor Pathway—IL2—thymus cancer	7.52e-05	0.00577	CbGpPWpGaD
Docetaxel—BCL2—IL-2 Signaling Pathway—AKT1—thymus cancer	7.42e-05	0.00569	CbGpPWpGaD
Docetaxel—BCL2—DNA Damage Response (only ATM dependent)—CDKN2A—thymus cancer	7.36e-05	0.00565	CbGpPWpGaD
Docetaxel—BCL2—Corticotropin-releasing hormone—IL2—thymus cancer	7.3e-05	0.00561	CbGpPWpGaD
Docetaxel—KIF11—Hemostasis—IL2—thymus cancer	7.15e-05	0.00549	CbGpPWpGaD
Docetaxel—BCL2—Integrated Cancer Pathway—AKT1—thymus cancer	7.14e-05	0.00548	CbGpPWpGaD
Docetaxel—BCL2—Interleukin-11 Signaling Pathway—AKT1—thymus cancer	7.14e-05	0.00548	CbGpPWpGaD
Docetaxel—KIF11—Immune System—CD8A—thymus cancer	7.09e-05	0.00544	CbGpPWpGaD
Docetaxel—KIF11—Adaptive Immune System—CD4—thymus cancer	6.72e-05	0.00516	CbGpPWpGaD
Docetaxel—BCL2—Ceramide signaling pathway—AKT1—thymus cancer	6.66e-05	0.00512	CbGpPWpGaD
Docetaxel—EGFR—Bladder Cancer—TP53—thymus cancer	6.62e-05	0.00508	CbGpPWpGaD
Docetaxel—EGFR—Gastric Cancer Network 2—TP53—thymus cancer	6.62e-05	0.00508	CbGpPWpGaD
Docetaxel—BCL2—IL-3 Signaling Pathway—AKT1—thymus cancer	6.56e-05	0.00503	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—CYLD—thymus cancer	6.51e-05	0.005	CbGpPWpGaD
Docetaxel—EGFR—Constitutive PI3K/AKT Signaling in Cancer—KIT—thymus cancer	6.48e-05	0.00497	CbGpPWpGaD
Docetaxel—BCL2—Signaling events mediated by Stem cell factor receptor (c-Kit)—AKT1—thymus cancer	6.35e-05	0.00487	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—MAML2—thymus cancer	6.34e-05	0.00487	CbGpPWpGaD
Docetaxel—EGFR—SHP2 signaling—IL2—thymus cancer	6.24e-05	0.00479	CbGpPWpGaD
Docetaxel—ABCG2—Fluoropyrimidine Activity—TP53—thymus cancer	5.88e-05	0.00451	CbGpPWpGaD
Docetaxel—EGFR—PI-3K cascade—KIT—thymus cancer	5.83e-05	0.00448	CbGpPWpGaD
Docetaxel—BCL2—Caspase Cascade in Apoptosis—AKT1—thymus cancer	5.81e-05	0.00446	CbGpPWpGaD
Docetaxel—EGFR—Extracellular vesicle-mediated signaling in recipient cells—AKT1—thymus cancer	5.74e-05	0.0044	CbGpPWpGaD
Docetaxel—EGFR—PI3K/AKT activation—KIT—thymus cancer	5.69e-05	0.00437	CbGpPWpGaD
Docetaxel—BCL2—Kit receptor signaling pathway—AKT1—thymus cancer	5.65e-05	0.00434	CbGpPWpGaD
Docetaxel—EGFR—GAB1 signalosome—KIT—thymus cancer	5.65e-05	0.00434	CbGpPWpGaD
Docetaxel—EGFR—Role of LAT2/NTAL/LAB on calcium mobilization—KIT—thymus cancer	5.52e-05	0.00424	CbGpPWpGaD
Docetaxel—EGFR—Regulation of Telomerase—IL2—thymus cancer	5.5e-05	0.00422	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways in Glioblastoma—CDKN2A—thymus cancer	5.46e-05	0.00419	CbGpPWpGaD
Docetaxel—KIF11—Immune System—KIT—thymus cancer	5.33e-05	0.00409	CbGpPWpGaD
Docetaxel—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—thymus cancer	5.13e-05	0.00394	CbGpPWpGaD
Docetaxel—BCL2—Apoptosis—TP53—thymus cancer	5.04e-05	0.00387	CbGpPWpGaD
Docetaxel—MAPT—Apoptosis—TP53—thymus cancer	5.02e-05	0.00386	CbGpPWpGaD
Docetaxel—NR1I2—Gene Expression—MAML2—thymus cancer	4.76e-05	0.00366	CbGpPWpGaD
Docetaxel—BCL2—Apoptosis Modulation and Signaling—TP53—thymus cancer	4.73e-05	0.00363	CbGpPWpGaD
Docetaxel—MAPT—MAPK Signaling Pathway—TP53—thymus cancer	4.71e-05	0.00362	CbGpPWpGaD
Docetaxel—KIF11—Hemostasis—TP53—thymus cancer	4.59e-05	0.00352	CbGpPWpGaD
Docetaxel—MAPT—BDNF signaling pathway—AKT1—thymus cancer	4.5e-05	0.00345	CbGpPWpGaD
Docetaxel—EGFR—Signaling by SCF-KIT—KIT—thymus cancer	4.36e-05	0.00335	CbGpPWpGaD
Docetaxel—BCL2—Apoptosis—AKT1—thymus cancer	4.26e-05	0.00327	CbGpPWpGaD
Docetaxel—MAPT—Integrated Pancreatic Cancer Pathway—TP53—thymus cancer	4.25e-05	0.00326	CbGpPWpGaD
Docetaxel—EGFR—ErbB Signaling Pathway—TP53—thymus cancer	4.25e-05	0.00326	CbGpPWpGaD
Docetaxel—MAPT—Apoptosis—AKT1—thymus cancer	4.24e-05	0.00326	CbGpPWpGaD
Docetaxel—BCL2—Senescence and Autophagy in Cancer—TP53—thymus cancer	4.22e-05	0.00324	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling of activated FGFR—KIT—thymus cancer	4.17e-05	0.0032	CbGpPWpGaD
Docetaxel—EGFR—a6b1 and a6b4 Integrin signaling—AKT1—thymus cancer	4.15e-05	0.00318	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB4—KIT—thymus cancer	4.11e-05	0.00315	CbGpPWpGaD
Docetaxel—BCL2—DNA Damage Response (only ATM dependent)—TP53—thymus cancer	4.09e-05	0.00314	CbGpPWpGaD
Docetaxel—KIF11—Immune System—CD4—thymus cancer	4.07e-05	0.00313	CbGpPWpGaD
Docetaxel—MAPT—MAPK Signaling Pathway—AKT1—thymus cancer	3.98e-05	0.00305	CbGpPWpGaD
Docetaxel—BCL2—Corticotropin-releasing hormone—AKT1—thymus cancer	3.96e-05	0.00304	CbGpPWpGaD
Docetaxel—EGFR—Downstream signal transduction—KIT—thymus cancer	3.92e-05	0.00301	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR—KIT—thymus cancer	3.9e-05	0.003	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB2—KIT—thymus cancer	3.88e-05	0.00298	CbGpPWpGaD
Docetaxel—KIF11—Hemostasis—AKT1—thymus cancer	3.88e-05	0.00298	CbGpPWpGaD
Docetaxel—EGFR—DAP12 signaling—KIT—thymus cancer	3.86e-05	0.00297	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—CYLD—thymus cancer	3.85e-05	0.00296	CbGpPWpGaD
Docetaxel—GHRHR—GPCR downstream signaling—IL2—thymus cancer	3.84e-05	0.00295	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling events of B Cell Receptor (BCR)—KIT—thymus cancer	3.81e-05	0.00292	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CYLD—thymus cancer	3.79e-05	0.00291	CbGpPWpGaD
Docetaxel—KIF11—Immune System—IL2—thymus cancer	3.75e-05	0.00288	CbGpPWpGaD
Docetaxel—EGFR—Signaling events mediated by PTP1B—AKT1—thymus cancer	3.7e-05	0.00284	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR in disease—KIT—thymus cancer	3.63e-05	0.00279	CbGpPWpGaD
Docetaxel—EGFR—DAP12 interactions—KIT—thymus cancer	3.63e-05	0.00279	CbGpPWpGaD
Docetaxel—EGFR—Fc epsilon receptor (FCERI) signaling—KIT—thymus cancer	3.63e-05	0.00279	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR—KIT—thymus cancer	3.6e-05	0.00277	CbGpPWpGaD
Docetaxel—MAPT—Integrated Pancreatic Cancer Pathway—AKT1—thymus cancer	3.59e-05	0.00276	CbGpPWpGaD
Docetaxel—EGFR—Rac1/Pak1/p38/MMP-2 pathway—TP53—thymus cancer	3.57e-05	0.00274	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR in Cancer—KIT—thymus cancer	3.57e-05	0.00274	CbGpPWpGaD
Docetaxel—EGFR—Signaling by PDGF—KIT—thymus cancer	3.55e-05	0.00273	CbGpPWpGaD
Docetaxel—EGFR—Spinal Cord Injury—IL2—thymus cancer	3.54e-05	0.00272	CbGpPWpGaD
Docetaxel—GHRHR—Signaling by GPCR—IL2—thymus cancer	3.49e-05	0.00268	CbGpPWpGaD
Docetaxel—EGFR—Thromboxane A2 receptor signaling—AKT1—thymus cancer	3.48e-05	0.00267	CbGpPWpGaD
Docetaxel—BCL2—DNA Damage Response (only ATM dependent)—AKT1—thymus cancer	3.46e-05	0.00265	CbGpPWpGaD
Docetaxel—EGFR—B Cell Activation—KIT—thymus cancer	3.36e-05	0.00258	CbGpPWpGaD
Docetaxel—BCL2—Direct p53 effectors—TP53—thymus cancer	3.35e-05	0.00257	CbGpPWpGaD
Docetaxel—KIF11—Adaptive Immune System—AKT1—thymus cancer	3.35e-05	0.00257	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—KIT—thymus cancer	3.22e-05	0.00247	CbGpPWpGaD
Docetaxel—BCL2—Integrated Breast Cancer Pathway—TP53—thymus cancer	3.15e-05	0.00242	CbGpPWpGaD
Docetaxel—EGFR—LPA receptor mediated events—AKT1—thymus cancer	3.13e-05	0.0024	CbGpPWpGaD
Docetaxel—BCL2—Apoptosis—TP53—thymus cancer	3.09e-05	0.00237	CbGpPWpGaD
Docetaxel—EGFR—AGE/RAGE pathway—AKT1—thymus cancer	3.05e-05	0.00234	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways in Glioblastoma—TP53—thymus cancer	3.04e-05	0.00233	CbGpPWpGaD
Docetaxel—EGFR—Rac1/Pak1/p38/MMP-2 pathway—AKT1—thymus cancer	3.02e-05	0.00232	CbGpPWpGaD
Docetaxel—EGFR—Regulation of Telomerase—AKT1—thymus cancer	2.98e-05	0.00229	CbGpPWpGaD
Docetaxel—TUBB—Cell Cycle, Mitotic—CDKN2A—thymus cancer	2.95e-05	0.00226	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—KIT—thymus cancer	2.93e-05	0.00225	CbGpPWpGaD
Docetaxel—ABCG2—HIF-1-alpha transcription factor network—AKT1—thymus cancer	2.85e-05	0.00219	CbGpPWpGaD
Docetaxel—BCL2—Integrated Breast Cancer Pathway—AKT1—thymus cancer	2.66e-05	0.00205	CbGpPWpGaD
Docetaxel—TUBB—Cell Cycle—CDKN2A—thymus cancer	2.63e-05	0.00202	CbGpPWpGaD
Docetaxel—BCL2—Integrated Pancreatic Cancer Pathway—TP53—thymus cancer	2.61e-05	0.00201	CbGpPWpGaD
Docetaxel—BCL2—Apoptosis—AKT1—thymus cancer	2.61e-05	0.002	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways in Glioblastoma—AKT1—thymus cancer	2.57e-05	0.00197	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—KIT—thymus cancer	2.48e-05	0.0019	CbGpPWpGaD
Docetaxel—EGFR—Constitutive PI3K/AKT Signaling in Cancer—AKT1—thymus cancer	2.47e-05	0.0019	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—IL2—thymus cancer	2.46e-05	0.00189	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle, Mitotic—CDKN2A—thymus cancer	2.44e-05	0.00187	CbGpPWpGaD
Docetaxel—EGFR—Androgen receptor signaling pathway—AKT1—thymus cancer	2.4e-05	0.00185	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—KIT—thymus cancer	2.39e-05	0.00183	CbGpPWpGaD
Docetaxel—EGFR—Spinal Cord Injury—TP53—thymus cancer	2.27e-05	0.00174	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CYLD—thymus cancer	2.24e-05	0.00172	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle, Mitotic—CDKN2A—thymus cancer	2.23e-05	0.00171	CbGpPWpGaD
Docetaxel—EGFR—PI-3K cascade—AKT1—thymus cancer	2.23e-05	0.00171	CbGpPWpGaD
Docetaxel—BCL2—Focal Adhesion—AKT1—thymus cancer	2.22e-05	0.0017	CbGpPWpGaD
Docetaxel—BCL2—Integrated Pancreatic Cancer Pathway—AKT1—thymus cancer	2.21e-05	0.00169	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle—CDKN2A—thymus cancer	2.18e-05	0.00168	CbGpPWpGaD
Docetaxel—EGFR—PI3K/AKT activation—AKT1—thymus cancer	2.17e-05	0.00167	CbGpPWpGaD
Docetaxel—EGFR—GAB1 signalosome—AKT1—thymus cancer	2.16e-05	0.00165	CbGpPWpGaD
Docetaxel—EGFR—Role of LAT2/NTAL/LAB on calcium mobilization—AKT1—thymus cancer	2.11e-05	0.00162	CbGpPWpGaD
Docetaxel—EGFR—ErbB1 downstream signaling—AKT1—thymus cancer	2.11e-05	0.00162	CbGpPWpGaD
Docetaxel—GHRHR—GPCR downstream signaling—AKT1—thymus cancer	2.08e-05	0.0016	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—IL2—thymus cancer	2.06e-05	0.00158	CbGpPWpGaD
Docetaxel—KIF11—Immune System—AKT1—thymus cancer	2.03e-05	0.00156	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle—CDKN2A—thymus cancer	2e-05	0.00153	CbGpPWpGaD
Docetaxel—EGFR—Direct p53 effectors—TP53—thymus cancer	1.98e-05	0.00152	CbGpPWpGaD
Docetaxel—GHRHR—Signaling by GPCR—AKT1—thymus cancer	1.89e-05	0.00145	CbGpPWpGaD
Docetaxel—EGFR—Integrated Breast Cancer Pathway—TP53—thymus cancer	1.87e-05	0.00143	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CD8A—thymus cancer	1.85e-05	0.00142	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—CD4—thymus cancer	1.83e-05	0.0014	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—CD8A—thymus cancer	1.81e-05	0.00139	CbGpPWpGaD
Docetaxel—ABCC1—Disease—MAML2—thymus cancer	1.75e-05	0.00134	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—TP53—thymus cancer	1.71e-05	0.00131	CbGpPWpGaD
Docetaxel—EGFR—Signaling by SCF-KIT—AKT1—thymus cancer	1.66e-05	0.00128	CbGpPWpGaD
Docetaxel—EGFR—Disease—MAML2—thymus cancer	1.65e-05	0.00126	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling of activated FGFR—AKT1—thymus cancer	1.59e-05	0.00122	CbGpPWpGaD
Docetaxel—EGFR—Integrated Breast Cancer Pathway—AKT1—thymus cancer	1.58e-05	0.00121	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB4—AKT1—thymus cancer	1.57e-05	0.0012	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—TP53—thymus cancer	1.55e-05	0.00119	CbGpPWpGaD
Docetaxel—ABCB1—HIF-1-alpha transcription factor network—AKT1—thymus cancer	1.54e-05	0.00118	CbGpPWpGaD
Docetaxel—EGFR—Downstream signal transduction—AKT1—thymus cancer	1.5e-05	0.00115	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR—AKT1—thymus cancer	1.49e-05	0.00114	CbGpPWpGaD
Docetaxel—EGFR—EGF/EGFR Signaling Pathway—AKT1—thymus cancer	1.49e-05	0.00114	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB2—AKT1—thymus cancer	1.48e-05	0.00114	CbGpPWpGaD
Docetaxel—EGFR—DAP12 signaling—AKT1—thymus cancer	1.47e-05	0.00113	CbGpPWpGaD
Docetaxel—TUBB—Cell Cycle—TP53—thymus cancer	1.47e-05	0.00113	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling events of B Cell Receptor (BCR)—AKT1—thymus cancer	1.45e-05	0.00112	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—AKT1—thymus cancer	1.45e-05	0.00111	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—KIT—thymus cancer	1.41e-05	0.00108	CbGpPWpGaD
Docetaxel—BCL2—Immune System—KIT—thymus cancer	1.39e-05	0.00107	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR in disease—AKT1—thymus cancer	1.39e-05	0.00106	CbGpPWpGaD
Docetaxel—EGFR—DAP12 interactions—AKT1—thymus cancer	1.39e-05	0.00106	CbGpPWpGaD
Docetaxel—EGFR—Fc epsilon receptor (FCERI) signaling—AKT1—thymus cancer	1.39e-05	0.00106	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR—AKT1—thymus cancer	1.37e-05	0.00106	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR in Cancer—AKT1—thymus cancer	1.36e-05	0.00105	CbGpPWpGaD
Docetaxel—EGFR—Signaling by PDGF—AKT1—thymus cancer	1.36e-05	0.00104	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—KIT—thymus cancer	1.36e-05	0.00104	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—TP53—thymus cancer	1.32e-05	0.00102	CbGpPWpGaD
Docetaxel—EGFR—Focal Adhesion—AKT1—thymus cancer	1.31e-05	0.00101	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—AKT1—thymus cancer	1.31e-05	0.001	CbGpPWpGaD
Docetaxel—EGFR—B Cell Activation—AKT1—thymus cancer	1.28e-05	0.000985	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—AKT1—thymus cancer	1.23e-05	0.000943	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle—TP53—thymus cancer	1.21e-05	0.000933	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MAML2—thymus cancer	1.15e-05	0.000884	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—AKT1—thymus cancer	1.12e-05	0.000858	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle—TP53—thymus cancer	1.11e-05	0.000853	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CD8A—thymus cancer	1.1e-05	0.000841	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—CD4—thymus cancer	1.08e-05	0.000829	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CD4—thymus cancer	1.06e-05	0.000817	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—CD4—thymus cancer	1.04e-05	0.000796	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IL2—thymus cancer	9.79e-06	0.000752	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—AKT1—thymus cancer	9.45e-06	0.000725	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—AKT1—thymus cancer	9.12e-06	0.0007	CbGpPWpGaD
Docetaxel—NR1I2—Gene Expression—AKT1—thymus cancer	8.39e-06	0.000644	CbGpPWpGaD
Docetaxel—EGFR—Immune System—KIT—thymus cancer	8.23e-06	0.000631	CbGpPWpGaD
Docetaxel—ABCC1—Disease—KIT—thymus cancer	8.06e-06	0.000619	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thymus cancer	7.8e-06	0.000599	CbGpPWpGaD
Docetaxel—EGFR—Disease—KIT—thymus cancer	7.59e-06	0.000583	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thymus cancer	6.59e-06	0.000506	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—IL2—thymus cancer	6.34e-06	0.000486	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CD4—thymus cancer	6.29e-06	0.000483	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CD4—thymus cancer	6.16e-06	0.000473	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—AKT1—thymus cancer	6.1e-06	0.000468	CbGpPWpGaD
Docetaxel—EGFR—Disease—CD4—thymus cancer	5.81e-06	0.000446	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL2—thymus cancer	5.79e-06	0.000444	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—AKT1—thymus cancer	5.39e-06	0.000414	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—KIT—thymus cancer	5.32e-06	0.000408	CbGpPWpGaD
Docetaxel—BCL2—Immune System—AKT1—thymus cancer	5.31e-06	0.000408	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—AKT1—thymus cancer	5.18e-06	0.000397	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IL2—thymus cancer	3.74e-06	0.000287	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—AKT1—thymus cancer	3.64e-06	0.00028	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—AKT1—thymus cancer	3.44e-06	0.000264	CbGpPWpGaD
Docetaxel—EGFR—Immune System—AKT1—thymus cancer	3.14e-06	0.000241	CbGpPWpGaD
Docetaxel—ABCC1—Disease—AKT1—thymus cancer	3.07e-06	0.000236	CbGpPWpGaD
Docetaxel—EGFR—Disease—AKT1—thymus cancer	2.9e-06	0.000222	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—AKT1—thymus cancer	2.58e-06	0.000198	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—AKT1—thymus cancer	2.49e-06	0.000191	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TP53—thymus cancer	2.4e-06	0.000184	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—AKT1—thymus cancer	2.27e-06	0.000174	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—AKT1—thymus cancer	2.25e-06	0.000172	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—AKT1—thymus cancer	2.03e-06	0.000156	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—AKT1—thymus cancer	1.62e-06	0.000125	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—AKT1—thymus cancer	1.23e-06	9.4e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—AKT1—thymus cancer	7.55e-07	5.79e-05	CbGpPWpGaD
